邹文茂,李景辉,刘蕾,刘芙蓉,邓超,敖雪. 预先应用甲状腺素片对脓毒症大鼠肿瘤坏子因子-α和肺组织病理的影响[J]. 中国急救医学, 2018, 38(2): 179-183.
Zou Wen-mao, Li Jing-hui, Liu Lei, Liu Fu-rong, Deng Chao, Ao Xue. Effect of thyroxine pretreatment on tumor necrosis factor-α and lung pathology in septic rats. Chinese Journal of Critical Care Medicine, 2018, 38(2): 179-183.
[1]Utiger RD. Altered thyroid function in nonthyroidal illness and surgery. To treat or not to treat[J]. N Engl J Med, 1995, 333(23):1562-1563.
[2]杨连粤, 黄耿文. 外科危重病人正常甲状腺病态综合征的研究进展[J]. 中国实用外科杂志, 2000, 20(2):114-115.
[3]van Tienhoven-Wind LJ, Dullaart RP. Tumor Necrosis Factor-alpha is Inversely Related to Free Thyroxine in Euthyroid Subjects Without Diabetes[J]. Horm Metab Res, 2017, 49(2):95-102.
[4]李欣. 右美托咪定对脓毒症大鼠炎症反应作用及其机制的研究[D]. 长沙: 中南大学, 2013.
[5]肖雪飞. 姜黄素对脓毒症急性肺损伤大鼠的保护作用及分子机制研究[D]. 长沙:中南大学, 2012.
[6]Ergin B, Guerci P, Zafrani L, et al. Effects of N-acetylcysteine (NAC) supplementation in resuscitation fluids on renal microcirculatory oxygenation, inflammation, and function in a rat model of endotoxemia[J]. Intensive Care Med Exp, 2016, 4(1):29.
[7]王慧琦,陈远卓,李丛烨,等. 川芎嗪对脓毒症急性肺损伤的保护作用[J]. 同济大学学报(医学版),2014,35(5):20-25.
[8]Schlichting D, McCollam JS. Recognizing and managing severe sepsis: a common and deadly threat[J]. South Med J, 2007, 100(6): 594-600.
[9]李欣, 李景辉. 右美托咪定对脓毒症大鼠高迁移率族蛋白BI的作用[J]. 中南大学学报(医学版), 2015, 40(9):987-992.
[10]杨泉涌. 预先应用甲状腺激素对心肌缺血-再灌注损伤保护作用的实验和临床研究[D]. 北京: 北京协和医学院, 2009.
[11]Rittirsch D, Huber-Lang MS, Flierl MA, et al. Immunodesign of experimental sepsis by cecal ligation and puncture [J]. Nat Protoc, 2009, 4(1):31-36.
[12]Phillips RH, Valente WA, Caplan ES, et al. Circulating thyroid hormone changes in acute trauma: prognostic implications for clinical outcome [J]. J Trauma, 1984, 24(2):116-119.
[13]Huang G, Yang L. Role of thyroid hormone in the protection of intestinal mucosal barrier of septic rats[J]. Chinese Journal of Experimental Surgery, 2000,17:531-532.
[14]Halabe CJ, Nellen HH, Gordon BF, et al. Thyroid function and abdominal surgery. A longitudinal study[J]. Arch Med Res,1992, 23(3):143-147.
[15]杨连粤, 刘合利. 甲状腺素在外科中的应用[J]. 中国实用外科杂志, 2001, 21(6):328-329.
[16]Vardarli I, Schmidt R, Wdowinski JM, et al. The hypothalamo-〖JP〗hypophyseal thyroid axis, plasma protein concentrations and the hypophyseo-gonadal axis in low T3 syndrome following acute myocardial infarct [J]. Klin Wochenschr, 1987, 65(3):129-133.
[17]Eber B, Schumacher M, Langsteger W, et al. Changes in thyroid hormone parameters after acute myocardial infarction[J]. Cardiology, 1995, 86(2): 152-156.
[18]杨连粤, 胡敏. 重症感染性休克与甲状腺激素外周代谢障碍关系的探讨[J]. 中华实验外科杂志, 1990, 7(3):134-135.
[19]Adler SM, Wartofsky L. The nonthyroidal illness syndrome[J]. Endocrinol Metab Clin North Am, 2007, 36(3): 657-672.
[20]Chinga-Alayo E, Villena J, Evans AT, et al. Thyroid hormone levels improve the prediction of mortality among patients admitted to the intensive care unit[J]. Intensive Care Med,2005,31(10):1356-1361.
[21]Dulchavsky SA, Bailey J. Triiodothyronine treatment maintains surfactant synthesis during sepsis[J]. Surgery, 1992, 112(2): 475-479.
[22]Jeevanandam V, Todd B, Regillo T, et al. Reversal of donor myocardial dysfunction by triiodothyronine replacement therapy[J]. J Heart Lung Transplant, 1994, 13(4):681-687.
[23]Chapital AD, Hendrick SR, Lloyd L, et al. The effects of triiodothyronine augmentation on antithrombin Ⅲ levels in sepsis[J]. Am Surg, 2001, 67(3):253-256.
[24]Moley JF, Ohkawa M, Chaudry IH, et al. Hypothyroidism abolishes the hyperdynamic phase and increases susceptibility to sepsis[J]. J Surg Res, 1984, 36(3):265-273.
[25]Yang ZL, Yang LY, Huang GW, et al. Tri-iodothyronine supplement protects gut barrier in septic rats[J]. World J Gastroenterol, 2003, 9(2): 347-350.
[26]刘军桂. 甲状腺素对肠缺血—再灌注肠黏膜屏障功能的保护作用[D]. 延边大学, 2005.
[27]Katzeff HL, Powell SR, Ojamaa K. Alterations in cardiac contractility and gene expression during low-T3 syndrome: prevention with T3[J]. Am J Physiol, 1997, 273(5 Pt 1):E951-956.
[28]Zaletel K, Gaberscek S. Hashimoto′s Thyroiditis: From Genes to the Disease[J]. Curr Genomics, 2011,12(8):576-588.
[29]Twig G, Shina A, Amital H, et al. Pathogenesis of infertility and recurrent pregnancy loss in thyroid autoimmunity[J]. J Autoimmun, 2012, 38(2-3):J275-281.
[30]Brenta G, Schnitman M, Fretes O, et al. Comparative efficacy and side effects of the treatment of euthyroid goiter with levo-thyroxine or triiodothyroacetic acid[J]. J Clin Endocrinol Metab, 2003, 88(11):5287-5292.
[31]Faure P, Oziol L, Artur Y, et al. Thyroid hormone (T3) and its acetic derivative (TA3) protect low-density lipoproteins from oxidation by different mechanisms[J]. Biochimie, 2004, 86(6):411-418.
[32]Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)[J]. JAMA, 2016, 315(8):801-810.
[33]Riedemann NC, Guo RF, Ward PA. The enigma of sepsis[J]. J Clin Invest, 2003, 112(4): 460-467.
[34]Martin GS, Mannino DM, Eaton S, et al. The epidemiology of sepsis in the United States from 1979 through 2000[J]. N Engl J Med, 2003, 348(16):1546-1554.
[35]Awad SS. State-of-the-art therapy for severe sepsis and multisystem organ dysfunction[J]. Am J Surg, 2003, 186(5A): 23S-30S.
[36]蒋建红,刘文明,杨汆,等. 阿托伐他汀对脓毒症大鼠肺组织病理及血清TNF-α、HMGB-1的影响[J]. 疑难病杂志, 2014,13(12):1283-1285.
[37]Fowler AA, Hamman RF, Good JT, et al. Adult respiratory distress syndrome: risk with common predispositions[J]. Ann Intern Med, 1983, 98(5 Pt 1):593-597.
[38]Grommes J, Soehnlein O. Contribution of neutrophils to acute lung injury [J]. Mol Med, 2011, 17(3-4):293-307.
[39]Bone RC. Immunologic dissonance: a continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS)[J]. Ann Intern Med, 1996, 125(8):680-687.
[40]Ge QG, Zhu X, Yao GQ, et al. Epidemiological investigation on acute respiratory distress syndrome occurring in intensive care units in Beijing from 1998 to 2003 [J]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue,2007,19(4):201-204.
[41]Rubenfeld GD, Caldwell E, Peabody E, et al. Incidence and outcomes of acute lung injury[J]. N Engl J Med,2005,353(16):1685-1693.
[42]Brun-Buisson C, Minelli C, Bertolini G, et al. Epidemiology and outcome of acute lung injury in European intensive care units. Results from the ALIVE study[J]. Intensive Care Med,2004,30(1):51-61.
[43]Angus DC, Clermont G, Linde-Zwirble WT, et al. Healthcare costs and long-term outcomes after acute respiratory distress syndrome: A phase Ⅲ trial of inhaled nitric oxide[J]. Crit Care Med,2006,34(12):2883-2890. [44]Erickson SE, Martin GS, Davis JL, et al. Recent trends in acute lung injury mortality: 1996-2005[J]. Crit Care Med,2009,37(5):1574-1579.
[45]Gupta N, Matthay MA. Sepsis and stretch: synergistic effects on alveolar epithelial cell death [J]. Crit Care Med,2006,34(6):1846-1847.
[46]Zhou M, Wu R, Dong W, et al. Endotoxin downregulates peroxisome proliferator-activated receptor-gamma via the increase in TNF-alpha release[J]. Am J Physiol Regul Integr Comp Physiol,2008,294(1):R84-92.
[47]郑晖,许绍发,苏跃,等. 内毒素复合油酸二次打击致大鼠急性肺损伤模型的建立[J]. 北京医学, 2010,32(8):637-640.
[48]崔青松, 金明根. 细胞因子及炎性介质在急性呼吸窘迫综合征中的作用研究进展[J]. 延边大学医学学报, 2009, 32(1):67-71.
[49]李超然,王智刚,朱运奎. 内毒素所致急性肺损伤发病机制的研究进展[J]. 中国医药科学, 2011,1(10):47-49.